- Home
- WF vs ASND Comparison
WF vs ASND Comparison
Compare WF & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WF
- ASND
- Stock Information
- Founded
- WF 1899
- ASND 2006
- Country
- WF South Korea
- ASND Denmark
- Employees
- WF N/A
- ASND N/A
- Industry
- WF Commercial Banks
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- WF Finance
- ASND Health Care
- Exchange
- WF Nasdaq
- ASND Nasdaq
- Market Cap
- WF 13.8B
- ASND 12.0B
- IPO Year
- WF N/A
- ASND 2015
- Fundamental
- Price
- WF N/A
- ASND $208.71
- Analyst Decision
- WF
- ASND Strong Buy
- Analyst Count
- WF 0
- ASND 16
- Target Price
- WF N/A
- ASND $244.19
- AVG Volume (30 Days)
- WF 40.5K
- ASND 450.0K
- Earning Date
- WF 10-24-2025
- ASND 11-13-2025
- Dividend Yield
- WF 4.04%
- ASND N/A
- EPS Growth
- WF 6.29
- ASND N/A
- EPS
- WF 2.73
- ASND N/A
- Revenue
- WF $7,611,646,475.00
- ASND $576,332,355.00
- Revenue This Year
- WF N/A
- ASND $102.31
- Revenue Next Year
- WF $2.46
- ASND $76.44
- P/E Ratio
- WF $6.26
- ASND N/A
- Revenue Growth
- WF N/A
- ASND 54.50
- 52 Week Low
- WF $29.44
- ASND $118.03
- 52 Week High
- WF $57.97
- ASND $216.45
- Technical
- Relative Strength Index (RSI)
- WF 36.63
- ASND 59.47
- Support Level
- WF $55.35
- ASND $187.25
- Resistance Level
- WF $56.50
- ASND $214.76
- Average True Range (ATR)
- WF 1.19
- ASND 5.80
- MACD
- WF -0.53
- ASND 0.73
- Stochastic Oscillator
- WF 9.10
- ASND 78.02
About WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. The operating segments of the company include Banking, Credit card, Capital, Investment banking, and others.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.